Adjunctive Therapy for Severe Acne
Trusted Efficacy
- The strongest single once-a-day dose of doxycycline monohydrate capsules available1
- Virtually neutral pH (5 to 6)2
- Study demonstrated no significant difference in adverse side effects resulting from taking postprandial Adoxa 150 mg, 100 mg or placebo3*
Added Convenience
- One prescription—up to two months' dosing
- 60 count bottle
*Single-blinded cross-over study with 60 healthy volunteers randomized with once-daily (tablet) dosing during two seven-day cycles, separated by a seven-day washout period.
Important Product Safety Information
ADOXA® is indicated as adjunctive therapy for severe acne.
ADOXA® Capsules are contraindicated in persons who have shown any sensitivity to any of the tetracyclines. THE USE OF DRUGS OF THE TETRACYCLINE CLASS DURING TOOTH DEVELOPMENT (LAST HALF OF PREGNANCY, INFANCY, AND CHILDHOOD TO THE AGE OF 8 YEARS) MAY CAUSE PERMANENT DISCOLORATION OF THE TEETH (YELLOW-GRAY-BROWN). Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Treatment should be discontinued at first evidence of skin erythema. Concurrent use of tetracycline may render oral contraceptives less effective.
For more information, consult your healthcare provider. Please see the link to the Full Prescribing Information below.
NO GENERIC SUBSTITUTE
ADOXA® (Doxycycline) Capsules Full Prescribing Information
References:
- US Food and Drug Administration Web site. Available at: www.accessdata.fda.gov/scripts/cder/drugsat/indez.cfm. Accessed April 3, 2008
- Maibach H. Second generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis. 1991;48(5):411-417.
- Leyden JJ, Kaidbey K. A Comparison of the Tolerance and Safety of Two Dosages of ADOXAŽ (Doxycycline Monohydrate) Compared to a Placebo In Healthy Human Volunteers. Study conducted November 2005 at Ivy Laboratories (KGL, Inc.), Broomall, PA (Study performed on tablets).
